Patterns of Triptans Use: A Study Based on the Records of a Community Pharmaceutical Department
- 1 September 2007
- journal article
- Published by SAGE Publications in Cephalalgia
- Vol. 27 (9), 1000-1004
- https://doi.org/10.1111/j.1468-2982.2007.01401.x
Abstract
Studies performed in selected populations show that the use of triptans for migraine is low. Our study was aimed at establishing patterns of triptan utilization in a large community using the drug prescription database of a regional Health Authority in Italy. In a population of 224 065 residents, 0.55% received at least one prescription of triptans in 1 year: 77.9% were female and 22.1% male. Oral dosage forms accounted for 94% of prescriptions. About 60% of patients received a single prescription (containing one or two packages) of one triptan in 1 year. Age distribution showed that 7% of patients were aged >65 years. They received 14% of packages, prevalently sumatriptan and zolmitriptan (the two triptans with the longest commercialization in Italy); 5.7% of patients received 40% of packages. Moreover, 3.2% of triptans users received >120 dosage units in the year in the form of tablets (>10 single doses/month), and were potential triptan abusers. Our data indicate suboptimal treatment of migraine patients and also incorrect treatment of some patients (potential triptans abusers, the elderly).Keywords
This publication has 17 references indexed in Scilit:
- Evolution of Migraine After a 10‐Year Follow‐UpHeadache: The Journal of Head and Face Pain, 2005
- Prognosis of migraine and tension-type headacheNeurology, 2005
- Patterns of Specific Antimigraine Drug use – A Study Based on the Records of 18 Community PharmaciesCephalalgia, 2005
- Recognition and Management of Migraine in Primary Care: Influence of Functional Impact Measured by the Headache Impact Test (HIT)Cephalalgia, 2005
- Single Use of Sumatriptan: A Patient Interview StudyHeadache: The Journal of Head and Face Pain, 2003
- Migraine Prevalence and Treatment Patterns: The Global Migraine and Zolmitriptan Evaluation SurveyHeadache: The Journal of Head and Face Pain, 2003
- Oral triptans (serotonin 5-HT1B/1D agonists) in acute migraine treatment: a meta-analysis of 53 trialsThe Lancet, 2001
- Migraine Diagnosis and Treatment: Results From the American Migraine Study IIHeadache: The Journal of Head and Face Pain, 2001
- An Epidemiological Study to Assess Migraine Prevalence in a Sample of Italian Population Presenting to Their GPsEuropean Neurology, 2000
- Use of sumatriptan in Denmark in 1994–5: an epidemiological analysisof nationwide prescription dataBritish Journal of Clinical Pharmacology, 1997